论文部分内容阅读
目的:研究神经节苷脂治疗新生儿缺氧缺血性脑病的临床效果。方法:将2015年6月到2016年12月期间于我院接受治疗的缺血缺氧性脑病新生儿100例作为研究对象,将其按照家属意愿均分为对照组和试验组。给予对照组患儿常规治疗,在对照组的基础上给予试验组患儿神经节苷脂治疗,比较两组患儿的临床治疗效果。结果:试验组患儿的临床治疗总有效率为94.00%,对照组治疗总有效率为70.00%,试验组治疗总有效率明显高于对照组,两组数据相比P<0.05。结论:神经节苷脂治疗新生儿缺氧缺血性脑病的效果较高,能明显提升其治疗有效率,具有较高临床推广价值。
Objective: To study the clinical effect of ganglioside on neonatal hypoxic-ischemic encephalopathy. Methods: 100 newborns with hypoxic-ischemic encephalopathy who were treated in our hospital from June 2015 to December 2016 were selected as the research object, which were divided into control group and experimental group according to their wishes. The control group of children given conventional treatment, in the control group based on the administration of ganglioside in children with experimental group, the clinical efficacy of the two groups were compared. Results: The total clinical effective rate was 94.00% in the experimental group and 70.00% in the control group. The total effective rate in the experimental group was significantly higher than that in the control group, P <0.05. Conclusion: Gangliosides treatment of neonatal hypoxic-ischemic encephalopathy effect is higher, can significantly improve the treatment efficiency, with high clinical value.